EC Number   |
Disease  |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    1.14.17.1 | Alzheimer Disease |
6633940 |
Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type. |
causal interaction
ongoing research
unassigned |
1
2
0 |
| 1.14.17.1 | Alzheimer Disease |
6779929 |
Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 1.14.17.1 | Alzheimer Disease |
7276979 |
Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. |
causal interaction
diagnostic usage
unassigned |
3
3
0 |
| 1.14.17.1 | Alzheimer Disease |
15305112 |
Increased lymphocyte dopamine beta-hydroxylase immunoreactivity in Alzheimer's disease: compensatory response to cholinergic deficit? |
causal interaction
unassigned |
3
0 |
| 1.14.17.1 | Alzheimer Disease |
16421143 |
Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk. |
causal interaction
unassigned |
3
0 |
| 1.14.17.1 | Alzheimer Disease |
23416088 |
Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease. |
therapeutic application
unassigned |
1
0 |
| 1.14.17.1 | Alzheimer Disease |
30453293 |
Association of Dopamine Beta-Hydroxylase Polymorphisms with Alzheimer's Disease, Parkinson's Disease and Schizophrenia: Evidence Based on Currently Available Loci. |
causal interaction
unassigned |
4
0 |
| 1.14.17.1 | Amebiasis |
23105547 |
Neurohumoral alterations and their role in amoebiasis. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
1
0 |
| 1.14.17.1 | Amnesia |
19771 |
Some characteristics of amnesia induced by FLA-63 an inhibitor of dopamine beta hydroxylase. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
1
4
0 |
| 1.14.17.1 | Amnesia |
228318 |
Clonidine reverses the amnesia induced by dopamine beta hydroxylase inhibition. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
1
1
0 |
